CD8A and neoplasm: On the other hand, butyrate (derived from Faecalibacterium, Roseburia, and Akkermansia) could modulate antitumor immunity by down-regulating IL-10 and programmed death ligand 1 (PD-L1) in tumor-associated macrophages, while enhancing CD8+ T-cell cytotoxicity [66,67].